Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

Comi G, O'Connor P, Montalban X, Antel J, Radue EW, Karlsson G, Pohlmann H, Aradhye S, Kappos L; FTY720D2201 Study Group.

Mult Scler. 2010 Feb;16(2):197-207. doi: 10.1177/1352458509357065. Epub 2009 Dec 22.

PMID:
20028707
2.

Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study.

O'Connor P, Comi G, Montalban X, Antel J, Radue EW, de Vera A, Pohlmann H, Kappos L; FTY720 D2201 Study Group.

Neurology. 2009 Jan 6;72(1):73-9. doi: 10.1212/01.wnl.0000338569.32367.3d.

PMID:
19122034
3.

Alternative methods of treatment used by multiple sclerosis patients in Poland.

Fryze W, Mirowska-Guzel D, Wiszniewska M, Darda-Ledzion L, Członkowski A, Członkowska A.

Neurol Neurochir Pol. 2006 Sep-Oct;40(5):386-90.

PMID:
17103351

Supplemental Content

Loading ...
Support Center